Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 1
2011 5
2013 2
2014 9
2015 5
2016 5
2017 4
2018 8
2019 12
2020 9
2021 13
2022 15
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators. Maurer MS, et al. N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27. N Engl J Med. 2018. PMID: 30145929 Free article. Clinical Trial.
Real-World Efficacy of Tafamidis in Patients With Transthyretin Amyloidosis and Heart Failure.
Ghoneem A, Bhatti AW, Khadke S, Mitchell J, Liu J, Zhang K, Trachtenberg B, Wechalekar A, Cheng RK, Baron SJ, Nohria A, Lenihan D, Ganatra S, Dani SS. Ghoneem A, et al. Among authors: trachtenberg b. Curr Probl Cardiol. 2023 Jun;48(6):101667. doi: 10.1016/j.cpcardiol.2023.101667. Epub 2023 Feb 23. Curr Probl Cardiol. 2023. PMID: 36828040 Review.
Rapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular Inflammation.
Boada C, Zinger A, Tsao C, Zhao P, Martinez JO, Hartman K, Naoi T, Sukhoveshin R, Sushnitha M, Molinaro R, Trachtenberg B, Cooke JP, Tasciotti E. Boada C, et al. Among authors: trachtenberg b. Circ Res. 2020 Jan 3;126(1):25-37. doi: 10.1161/CIRCRESAHA.119.315185. Epub 2019 Oct 24. Circ Res. 2020. PMID: 31647755 Free article.
Inflammatory Cardiomyopathic Syndromes.
Trachtenberg BH, Hare JM. Trachtenberg BH, et al. Circ Res. 2017 Sep 15;121(7):803-818. doi: 10.1161/CIRCRESAHA.117.310221. Circ Res. 2017. PMID: 28912184 Review.
Insights on Infiltrative and Restrictive Cardiomyopathies.
Trachtenberg B, Kassi M. Trachtenberg B, et al. Methodist Debakey Cardiovasc J. 2022 Mar 14;18(2):1-3. doi: 10.14797/mdcvj.1098. eCollection 2022. Methodist Debakey Cardiovasc J. 2022. PMID: 35414859 Free PMC article. No abstract available.
Future Directions in Cardio-Oncology.
Trachtenberg BH. Trachtenberg BH. Methodist Debakey Cardiovasc J. 2019 Oct-Dec;15(4):300-302. doi: 10.14797/mdcj-15-4-300. Methodist Debakey Cardiovasc J. 2019. PMID: 31988691 Free PMC article. Review. No abstract available.
The Burgeoning Field of Cardio-Oncology.
Trachtenberg BH. Trachtenberg BH. Methodist Debakey Cardiovasc J. 2019 Oct-Dec;15(4):241-242. doi: 10.14797/mdcj-15-4-241. Methodist Debakey Cardiovasc J. 2019. PMID: 31988683 Free PMC article. No abstract available.
Circulating hemopexin modulates anthracycline cardiac toxicity in patients and in mice.
Liu J, Lane S, Lall R, Russo M, Farrell L, Debreli Coskun M, Curtin C, Araujo-Gutierrez R, Scherrer-Crosbie M, Trachtenberg BH, Kim J, Tolosano E, Ghigo A, Gerszten RE, Asnani A. Liu J, et al. Among authors: trachtenberg bh. Sci Adv. 2022 Dec 23;8(51):eadc9245. doi: 10.1126/sciadv.adc9245. Epub 2022 Dec 23. Sci Adv. 2022. PMID: 36563141 Free PMC article.
93 results